intercellular adhesion molecule-1), where they are believed to contribute to endothelial activation, microvascular obstruction, localized hypoxia, and associated tissue injury. Malarial retinopathy has emerged as a powerful tool to better define the pathobiology of severe disease. Specific retinal changes-hemorrhages, retinal whitening, or vessel abnormalities-have been found to be associated with CM. Because the retina and the brain are formed from the same embryonic tissue and have analogous bloodtissue barriers, analysis of retinopathy can provide insights into microvascular and tissue disturbances in the brain that are otherwise difficult to study. Ophthalmoscopy combined with retinal angiography has demonstrated that retinal whitening is associated with areas of nonperfusion; vessel abnormalities are indicative of nonperfusion of vessels (white coloration) or areas of reduced vascular lumen (orange coloration) (5) , and hemorrhage corresponds to focal loss of blood-retinal barrier integrity. Consistent with these observations and their associated brain pathology, retinopathy is associated with worse outcome in cerebral malaria (6 -8) .
The vascular pathology observed on retinal examination and at autopsy point to a key role for endothelial activation and dysfunction during the development of CM. The endothelium represents the critical interface between the brain parenchyma and the intravascular compartment containing sequestered parasites. In 75% of fatal CM cases, sequestration was associated with intravascular and perivascular pathology, including microthrombus formation, perivascular edema, and ring hemorrhages in the brain parenchyma surrounding ruptured vessels (9, 10) . Markers of endothelial activation are increased in the plasma of patients with malaria and have been positively correlated with disease severity (11) (12) (13) (14) (15) (16) . Collectively these observations suggest a role for endothelial activation and loss of barrier integrity in the pathophysiology of CM.
The angiopoietin-Tie-2 system has been shown to regulate endothelial cell function and vascular integrity (17, 18) . Angiopoietin-1 (Ang-1) engages endothelial receptor Tie-2, promoting endothelial cell quiescence and survival, whereas these effects are generally inhibited by angiopoietin-2 (Ang-2) (19) . Previous reports have demonstrated low Ang-1 and elevated Ang-2 levels in severe compared with uncomplicated malaria (20 -22) . In this study, we investigated markers of the angiopoietin-Tie-2 system in CM in relation to retinal findings and clinical outcome. We hypothesized that altered levels of Ang-1, Ang-2, and the soluble form of Tie-2 (sTie-2) would be associated with retinopathy and would correlate with the severity of retinal changes. Because endothelium may have a crucial role in mediating malaria pathogenesis, we further postulated that these markers would have prognostic value in CM. We show that decreases in Ang-1 and increases in Ang-2 and sTie-2 are associated with retinopathy and mortality. We also show that Ang-2 is a clinically informative prognostic biomarker alone or in combination with clinical findings.
MATERIALS AND METHODS
Ethics. Ethical approval for this study was granted from The College of Medicine Research Ethics Committee in Blantyre, Malawi, and all parents or guardians gave written informed consent for children to enter the study. This was a retrospective case-control study of plasma samples collected as part of ongoing prospective studies of the pathogenesis and management of CM.
Study Population. Children between 6 months and 14 yrs of age presenting with fever to the Queen Elizabeth Central hospital in Blantyre, Malawi, were recruited between 1997 and 2009. Admission EDTA plasma samples were obtained from children after their parents or guardians had given their informed consent. Samples collected as part of ongoing prospective studies of the pathogenesis and management of CM were used to assess the relationship between endothelial regulatory proteins (Ang-1, Ang-2, sTie-2) and retinopathy and mortality. This retrospective casecontrol study examined children with clinically defined CM with retinopathy-positive children as cases and retinopathy-negative children as control subjects. The sample size was calculated based on a case:control ratio of 2:1 with 80% power to detect a clinically significant difference in Ang-2 levels based on data from a previous study of African children with CM at an ␣ of 0.05 (21) . Inclusion criteria included a clinical definition of CM (P. falciparum asexual parasitemia, a Blantyre Coma Score [BCS] Յ2 with no improvement after correction of hypoglycemia) and an available plasma sample with sufficient volume that had not undergone a previous freeze-thaw. Exclusion criteria included evidence of meningitis or any other identifiable cause for coma (9, 23) . All participants received standard treatment, including antimalarial and/or antibacterial therapy as indicated, according to Malawian national guidelines.
Ophthalmological Examination. After admission of a child with altered consciousness, the patient's pupils were dilated by application of mydriatic eye drops (tropicamide and phenylephrine) and the fundi were examined by direct and indirect ophthalmoscopy. The findings of an ophthalmologist or experienced clinician were recorded on standardized forms. Retinopathy was defined by the presence of any one of the following retinal findings: hemorrhages, retinal whitening, or vessel changes with or without papilledema, as previously described (24, 25) . Clinical grading of retinal changes was recorded as follows: 0 -4 for hemorrhages (0 ϭ none, 1 ϭ mild [1-5 hemorrhages], 2 ϭ moderate [Ͼ5 and Յ20 hemorrhages], 3 ϭ severe [Ͼ20 and Յ50 hemorrhages], 4 ϭ very severe [Ͼ50 hemorrhages]) and 0 -3 for papilledema, retinal whitening, orange vessels, white vessels, and white capillaries (0 ϭ none, 1 ϭ mild, 2 ϭ moderate, 3 ϭ severe) (26) . Papilledema alone did not constitute retinopathy.
Quantification of Biomarkers. Plasma concentrations of biomarkers Ang-1, Ang-2, and sTie-2 (DuoSets; R&D Systems, Minneapolis, MN) were measured by enzyme-linked immunosorbent assay "blinded" to other patient data, as previously described (27) .
Statistics. Comparisons of continuous variables were performed using the MannWhitney U test and Spearman rank correlation coefficient. Comparisons of proportions were performed using the Pearson chi-square test, linear-by-linear association, or Fisher's exact test. Odds ratios (ORs) were calculated using Pearson chi-square or logistic regression models to adjust for covariates. Bonferroni adjustment was used to account for multiple comparisons. Variables were included in logistic regression models as covariates if there was a significant association between the independent and dependent variable. Variables were excluded from multivariate models if Ͼ5% of the data were missing (to limit bias and reduction of power); the exception was thrombocytopenia, because platelets are a known source of Ang-1. Classification trees (CRT) were used to identify the biomarker cutoffs. The prognostic accuracy of biomarkers and individual laboratory findings were assessed using receiver operating characteristic curves. The area under the receiver operating characteristic curves or c-index was compared using the Delong-Delong Clarke Pearson method (28) .
Multivariable logistic regression and CRT were used to generate predictive models of mortality. All variables except age were dichotomized before inclusion in the logistic regression models to circumvent issues of nonlinearity and multicollinearity. Linearity of age with the log odds of the dependent variable (retinopathy and mortality) was confirmed by including a Box-Tidwell transformation into the model and ensuring that this term was not significant. Models were validated by ensuring the Hosmer-Lemeshow goodness-of-fit test was not significant (p Ͼ .10).
CRT was performed including all significant univariable predictors with the following settings: 50 cases for parent nodes and 25 for child nodes; a prior probability of death of 23.8% and a misclassification cost (i.e., misclassifying deaths as survivors) of 10; and crossvalidation with ten sample folds to generate an estimate of the misclassification rate (when available). Surrogates were used to classify cases for variables with missing values. Analysis was performed with GraphPad Prism version 5.0 (GraphPad Software Inc., La Jolla, CA), SPSS version 16.0 (SPSS Inc., Chicago, IL), and MedCalc (MedCalc Software bvba, Mariakerke, Belgium).
RESULTS
Patient Characteristics. One hundred fifty-five children between the ages of 8 months and 14 yrs were included in the study. All the children met the World Health Organization case definition for CM. Fifty subjects were retinopathynegative, 103 were retinopathy-positive, and two died before funduscopic examinations could be performed. Fifty-nine (38.1%) of the children included in this study died. All subjects had plasma samples collected and clinical characteristics recorded at admission. The demographic and clinical characteristics and laboratory findings at admission are summarized in Table 1 .
Biomarkers of Endothelial Activation Are Associated With Malaria Retinopathy. Based on the hypothesis that endothelial activation and dysfunction are central to the pathophysiology of cerebral malaria, markers of endothelial activation were measured in children with retinopathy compared with those without. Venous lactate, a validated biochemical marker of disease severity, was included as a comparator (29, 30) . Median Ang-1 levels were decreased (p ϭ .018), and median Ang-2 and sTie-2 levels were increased (p Ͻ .0001) in subjects with retinopathy compared with those without retinopathy (Fig. 1) . Venous lactate was also more elevated in children with malarial retinopathy than without (p ϭ .004).
The relationship between endothelial biomarkers and retinopathy was further examined after dichotomization of biomarkers. Biomarker levels (Ang-1 Յ6.76 ng/mL, Ang-2 Ͼ3.85 ng/mL, sTie-2 Ͼ67.8 ng/mL) were associated with an increased odds of having retinopathy ( Table [3.9 -35 .0], p Ͻ .001). Ang-2 and sTie-2 remained independent predictors of retinopathy after adjusting for covariates (Table 2: age, respiratory distress, severe anemia, thrombocytopenia, history of convulsions).
Relationship Between Specific Retinal Changes and the Angiopoietin-Tie2 Axis. The distribution of retinal changes for this population is described in Figure 2 . Whitening (94.5%) was the most common retinal change followed by vessel changes (76.9%) and hemorrhages (70.3%). Less than 10% of children had a single retinal change recorded, whereas 51.6% of children had all three retinal changes. Papilledema alone did not constitute retinopathy; only one child in the retinopathy-negative group had papilledema alone.
We assessed the severity of retinal changes using a standardized clinical score (see "Methods") (26, 31) . Ang-2 and sTie-2 concentrations correlated positively with the number of hemorrhages, the severity of retinal whitening, and the extent of white capillaries (Table 3 ; p Ͻ .05 after Bonferroni adjustment for multiple comparisons). Venous lactate concentrations correlated with retinal whitening (p Ͻ .05). Overall, Ang-2 and sTie-2 levels correlated with the severity of hemorrhage, retinal whitening, and white vessels (nonperfusion) but were not related to orange vessels (which probably represent parasite sequestration).
Biomarkers of Endothelial Activation Are Associated With Mortality. We next investigated the hypothesis that markers of endothelial activation would be associated with a poor prognosis. Increased median levels of Ang-2 and sTie-2 at admission, but not Ang-1, were associated with a fatal outcome (Fig. 3, top panel A-D: p Ͻ .0001). Venous lactate was also elevated in children who subsequently died (p ϭ .002). In the subset of children who were retinopathy-positive, Ang-2 alone was significantly more elevated in fatal cases than in survivors (p ϭ .027). We generated receiver operating characteristic curves to assess the prognostic accuracy of the biomarkers. Ang-2, sTie-2, and venous lactate had comparable area under the receiver operating characteristic curves: Ang-2 (area under the receiver operating characteristic curves [95% confidence interval]), 0.71 (0.63-0.78); sTie-2, 0.64 (0.55-0.73); and venous lactate, 0.67 (0.59 -0.78) (Fig. 3E-H) . Decision plots were constructed to visualize the tradeoff between sensitivity and specificity of the biomarkers at the various cutoffs along the receiver operating characteristic curve (Fig. 3I-L) . The cut points for each marker, as determined by CRT, are represented in the decision plots (Ang-1 Յ5.89 ng/mL, Ang-2 Ͼ3.85 ng/ mL, sTie-2 Ͼ67.8 ng/mL).
The relationship between endothelial biomarkers and mortality were further explored using logistic regression. Biomarker levels were associated with increased odds of death ( (Table  2: age, respiratory distress, BCS, severe anemia) with adjusted ORs of 7.9 (2.6 -23.6) and 2.5 (1.0 -5.9), respectively. Venous lactate and leukocyte count were excluded as a result of incomplete data.
Incorporating Ang-Tie2 Biomarkers Into Prognostic Clinical Models. We used logistic regression and CRT analysis to generate prognostic models using routine clinical parameters and the plasma biomarkers. A clinically predictive model of mortality was generated using parameters that are readily available to clinicians (age, BCS, respiratory distress, severe anemia). We used the predicted probabilities from this clinical model to (1) 14.3% (13) 4.4% (4) 8.8% (8) 19.8% (18) 51.6% (47) Data are presented as percentages followed by the number of children in each group. Detailed classification of retinal changes was available for 91 of the 103 retinopathy-positive children. A total of 70.3% children had hemorrhages (n ϭ 64), 94.5% had retinal whitening (n ϭ 86), and 76.9% had vessel abnormalities (n ϭ 70). Endothelial biomarkers dichotomized by classification tree: Ang-1 (cut point: Յ6.76 ng/mL retinopathy, Յ5.89 mortality), Ang-2 (cut point: Ͼ3.85 ng/mL), soluble Tie-2 (cut point: Ͼ67.80 ng/mL).
generate a c-index (equivalent to the area under the receiver operating characteristic curves) of 0.73 (95% confidence interval [CI], 0.65-0.79). Then, using the clinical model as a foundation, we added biomarker tests to determine whether they would significantly improve predictive accuracy. The clinical model including all three biomarkers had a c-index of 0.79 (0.72-0.84), which was significantly better than the clinical model alone (p ϭ .03). We assessed whether a more parsimonious model could be achieved using a single biomarker. Inclusion of Ang-2 alone (but not Ang-1 or sTie-2 alone) led to a model that was significantly better than the Spearman's correlating biomarker levels with clinical grading score of retinal components. Hemorrhage (0 ϭ none, 1 ϭ mild, 2 ϭ moderate, 3 ϭ severe, 4 ϭ very severe); whitening, vessel changes (orange vessels, white vessels, white capillaries), and papilledema (0 ϭ
CRT was used as an alternative method to develop a prognostic model. This intuitive approach generates a decision tree that is easy to interpret. CRT divides data into two mutually exclusive groups ("nodes") to maximize the homogeneity within each node. When all variables significantly associated with death were entered into the analysis, a decision tree was generated using Ang-2 at a cutoff of 3.85 ng/mL to discriminate between survivors and nonsurvivors. This model has 93.2% sensitivity to predict death and a misclassification rate of 23.1% (Fig.  4A) . Next, we explored models in which a clinical sign (BCS or respiratory distress) was entered as the first variable to integrate clinical parameters and reduce the number of biomarkers required for testing. In both clinically informed models, Ang-2 was useful for identifying nonsurvivors in comatose children considered lower risk (BCS 1 or 2 [as opposed to 0]; Fig. 4B , or children without respiratory distress; Fig. 4C ).
DISCUSSION
In this study, we provide evidence linking the angiopoietin-Tie-2 system to the clinical and pathologic findings of cerebral malaria and further suggest that the angiopoietins may be useful prognostic biomarkers in severe malaria. We demonstrate that perturbations in the angiopoietin-Tie-2 system are associated with retinopathic findings, which are likely reflective of pathologic changes in the brain (32) . Consistent with a role in malaria pathophysiology, elevated admission levels of Ang-2 and sTie-2 and decreased Ang-1 were associated with increased odds of subsequent death. Together, these data demonstrate an association between the angiopoietins and the microvascular disturbances involved in CM pathogenesis.
Angiopoietins engage the Tie family of receptor tyrosine kinases to regulate the vascular endothelium. Altered levels of Ang-1, Ang-2, and sTie-2 in this sample of children with severe malaria provide insights into a possible pathophysiologic role of the angiopoietin-Tie-2 system in mediating disease severity and outcome. In this study, elevated Ang-2 was associated with retinopathy ( Fig. 1; Table 2 ) and levels were positively correlated with the number of hemorrhages, the degree of retinal whitening, and the extent of white capillaries (Table 3) . Ang-2 is stored in intracellular vesicles called Weibel-Palade bodies and is rapidly mobilized and released after endothelial activation (33) . Ang-2 is thought to amplify endothelial activation by opposing the effects of Ang-1 (although it can exert partial agonist activity in the absence of Ang-1 [19] ). Previous studies have demonstrated that Ang-2 sensitizes the endothelium to subthreshold levels of tumor necrosis factor (34), increases endothelial cell permeability (18) , and promotes the upregulation of cellular adhesion molecules such as intercellular adhesion molecule-1 (18) . We hypothesize that Ang-2 promotes a positive feedback loop of endothelial activation, inflammation, and parasite sequestration. However, Ang-2 may simply be a reflection of endothelial activation and hypoxia (35, 36) and further studies will be required to determine its role in severe malaria.
sTie-2 was also associated with retinopathy and malaria severity. sTie-2 has been identified in supernatants from cultured endothelial cells, is present in normal human serum and plasma (37) , and has been identified as a biomarker in cancer (38 -40) , sepsis (41) , and ischemia (42) . It is shed from endothelial cells as a result of ectodomain cleavage by matrix metalloproteinases (43) , and this cleavage can be stimulated by a variety of physiological factors, including basic fibroblast growth factor and vascular endothelial growth factor (37, 42, 44) . To date, the function of sTie-2 is incompletely understood. sTie-2 can inhibit Ang-2 activity (45) , and thus it is plausible that sTie-2 produced during malaria infection counters the potentially detrimental effects of Ang-2. Ang-1 is released from mural cells (vascular smooth muscle cells and pericytes) and activated platelets and helps promote endothelial cell survival and maintain the integrity of endothelial tight junctions (46, 47) . Like Ang-2 and sTie-2, Ang-1 was associated with retinopathy; however, this relationship was lost after adjustment for thrombocytopenia. Platelet counts were reduced in retinopathy-positive children, consistent with other reports (25, 48) . Thus, decreased Ang-1 levels in retinopathy may reflect a decrease in platelet number and/or platelet Ang-1 content. Together, these data implicate the angiopoietinTie-2 system in the vascular dysfunction seen in cerebral malaria, but further studies will be required to investigate a possible causal role.
An additional aim of this study was to investigate the prognostic value of endothelial biomarkers in comatose children with CM. Admission levels of sTie-2 and Ang-2 were elevated in cases that subsequently progressed to a fatal outcome, and these biomarkers had discriminative value comparable to venous lactate, currently the best available biochemical marker for severe malaria in children (Fig. 3) (29, 30) . Admission plasma Ang-2 concentration remained a significant independent predictor of mortality after controlling for covariates (age, BCS, respiratory distress, severe anemia; Table 2) and Ang-2, not lactate, was considered the best predictor of death using classification analysis. This suggests that Ang-2 may have clinical use as a biomarker. These data could be further used to add prognostic value above and beyond clinical parameters (Fig. 4) . These results are in agreement with those of Yeo et al (20) , which show a significant association between Ang-2 levels and outcome in Asian adults.
Our data, together with previous reports, suggest that Ang-2 is a robust, quantitative, and objective marker of malaria severity that may have use in clinical practice to triage patients and monitor response to therapy. Ang-2 is elevated in severe compared with uncomplicated malaria and healthy control subjects across a range of ethnicities and ages (20, 22) and correlates with clinical progression or deterioration when measured longitudinally over the course of illness (20) . We show that Ang-2 predicts mortality independently of clinical signs. Given its recognized role as a mediator of endothelial activation, Ang-2 may be useful as a surrogate end point in clinical trials of adjunctive therapies for malaria that target the host endothelium (20) as well as affording a promising molecular target for intervention (49) .
The results of this study, although promising, must be interpreted with caution. The retrospective case-control design may introduce bias. This study only includes children with well-defined CM. Although this homogeneity in study participants enables us to better investigate the potential role of the biomarkers in disease pathogenesis, it may reduce the generalizability of the data. In addition, the case-control nature of the study precludes us from investigating whether Ang-2 is independently associated with retinopathy, mortality, or both. These results will need to be confirmed in larger prospective studies. Nonetheless, these data suggest that: 1) the angiopoietinTie-2 system may be involved in CM pathogenesis; and 2) Ang-2 is a promising prognostic biomarker in severe malaria. Predictive markers that could identify children with severe malaria at greatest risk of poor outcomes could enable better triage, allocation of resources, and selection of high-risk patients for evaluation of new adjunctive interventions.
